D-Fructose-6-phosphate (sodium salt hydrate)
| Code | Size | Price |
|---|
| TAR-T37985-500mg | 500mg | £124.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
D-Fructose-6-phosphate is a sugar intermediate of the glycolytic pathway formed by the isomerization of glucose-6-phosphate. It is in turn further phosphorylated to fructose-1,6-bisphosphate, which is one of the rate-limiting steps in glycolysis. Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a new target for cancer chemotherapy.1D-Fructose-6-phophate can be used to help identify, differentiate, and characterize the enzymes in this process.
CAS:
918149-30-1
Formula:
C6H13O9P.2Na [2H2O]
Molecular Weight:
342.1
Purity:
0.98
SMILES:
OCC([C@H]([C@@H]([C@@H](COP(O)(O)=O)O)O)O)=O.[Na].[Na].O.O
References
Seo, M., Kim, J.D., Neau, D., et al.Structure-based development of small molecule PFKFB3 inhibitors: A framework for potential cancer therapeutic agents targeting the Warburg effectPLoS One6(9)1-12(2011)